Tirzepatide 10 mg

Description

Tirzepatide 10 mg – Product Overview

Generic Name: Tirzepatide
Strength: 10 mg per dose (typically as a pre-filled subcutaneous injection pen)

Type of Medicine:
A once-weekly injectable peptide medication that functions as a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist. This “twincretin” action enhances insulin secretion, improves insulin sensitivity, reduces glucagon release, slows gastric emptying, and decreases appetite.

Indications:

• As an adjunct to diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus.
• For chronic weight management in adults with obesity or overweight with at least one weight-related condition (when prescribed under appropriate brand guidelines, e.g., Zepbound in some regions).

Administration:

• Subcutaneous (under-the-skin) injection once weekly.
• Typically started at a lower dose and titrated up over weeks; 10 mg is a common maintenance dose.

Mechanism of Action:

• Mimics endogenous incretin hormones (GIP and GLP-1).
• Stimulates glucose-dependent insulin secretion.
• Suppresses glucagon secretion when glucose levels are elevated.
• Slows gastric emptying and can reduce appetite.

Common Adverse Reactions:

Gastrointestinal effects are the most frequent, especially when initiating treatment or increasing dose, and may include:

• Nausea
• Diarrhea
• Vomiting
• Decreased appetite
• Constipation

Serious Risks & Warnings:

• Signal for thyroid C-cell tumors in animal studies — not confirmed in humans; contraindicated in people with a personal/family history of certain thyroid cancers or multiple endocrine neoplasia syndrome type 2.
• Rare but serious effects may include pancreatitis, gallbladder disease, severe hypoglycemia (especially when used with insulin or insulin secretagogues), and injection site reactions.

Storage & Handling:

Typically stored refrigerated (2–8 °C) and protected from light; may be kept at room temperature for limited periods per product labelling. Use only under healthcare supervision with proper training for injection technique.